NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional)
Description
The NIH Common Fund supports exceptionally creative early-stage investigators pursuing bold, high-impact biomedical or behavioral research without requiring preliminary data.
Eligibility
Early Stage Investigators proposing unusually innovative, high-impact work relevant to the NIH mission; single principal investigator and at least 25 percent research effort required.
Keywords
Related Job Opportunities
Postdoctoral Scientist - Sarvestani Lab
The Sarvestani Lab at Cornell University is recruiting a postdoctoral scientist in systems neuroscience to study how visual and motor systems across the brain and body support perception and…
ARISE2 Postdoctoral Fellowship - 2026 Call for Applications
EMBL's ARISE2 programme offers more than 20 fully funded, three-year postdoctoral fellowships for scientists developing research-infrastructure technologies across the life sciences, including…
PhD Studentship: Mitochondrial Metabolism and Novel Therapeutic Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (Fixed Term)
Supervisors: Professor Andrew Murray, Department of Physiology, Development and Neuroscience, University of Cambridge Dr Ross Lindsay, Novo Nordisk Funding: Fully funded PhD studentship (Home/UK…